Related Experiment Video

Updated: May 21, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNAs and prostate cancer: from preclinical research to translational oncology

Marcello Maugeri-Saccà1, Valeria Coppola, Désirée Bonci

  • 1Regina Elena National Cancer Institute, Rome, Italy. maugeri.marcello@gmail.com

Cancer Journal (Sudbury, Mass.)
|June 1, 2012
PubMed

Insights

New prostate cancer treatments improve survival, necessitating biomarkers for personalized care. MicroRNAs show promise as diagnostic, prognostic, and predictive tools in prostate cancer management.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Prostate cancer management is evolving with new therapies extending patient survival.
  • Identifying reliable biomarkers is crucial for guiding treatment decisions in this complex landscape.
  • MicroRNAs are implicated in cancer biology and hold potential as versatile biomarkers.

Purpose of the Study:

  • To review the current understanding of microRNA deregulation in prostate cancer.
  • To summarize the clinical investigation of microRNAs as biomarkers.
  • To outline strategies for optimizing microRNA biomarker potential.

Main Methods:

  • Literature review of studies on microRNA deregulation in prostate cancer.
  • Analysis of clinical trial data investigating microRNA biomarkers.
  • Synthesis of current knowledge and future research directions.

Main Results:

  • MicroRNA deregulation is a documented feature of prostate cancer.
  • MicroRNAs have been explored as diagnostic, prognostic, and predictive biomarkers in clinical settings.
  • Further research is needed to validate and refine microRNA biomarkers for clinical application.

Conclusions:

  • MicroRNAs represent a promising class of biomarkers for prostate cancer.
  • Validation and strategic development are key to realizing their clinical utility.
  • Harnessing microRNA potential can enhance personalized prostate cancer management.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...